Endothelial Dysfunction in Children with Clinically Stable and Exacerbated Asthma

Abstract

Introduction: In children with asthma, endothelial dysfunction signs are observed, and their extent depends on the severity of the disease. These changes are also present in remission. High level of soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) expression causes active adhesion of inflammatory cells and can indicate direct endothelium participation in development and supporting of chronic inflammation. Bronchial asthma (BA) is characterised by airways chronic inflammation. A special role in this inflammatory process formation is played by development of endothelial dysfunction. The aim of the study was to evaluate endothelial state in children with clinically stable and exacerbated asthma. Material and methods: 91 children with persistent asthma were examined. Among them there were 40 patients with mild persistent (group I), 34 subjects with moderate persistent (group II) and 17 individuals with severe persistent (group III) asthma. 20 healthy children were selected as controls. The serum levels of sVCAM-1 were determined by enzyme-linked immunosorbent assay (ELISA). The ultrasound assessment of endothelium-dependent flow-mediated dilation of the brachial artery (FMD%) has been made. Ultrasonography has been used for investigation of the intima-media thickness (I-M) complex. Data analysis was performed with the Statsoft Statistica Version 8 (Tulsa, OK). Results: The serum levels of sVCAM-1 were significantly increased in the patients with asthma exacerbation (p < 0.001) and remission (p < 0.001), compared with the controls. The index of FMD% was significantly diminished in the patients of I, II, III group with exacerbation (p < 0.001) and stayed lower in the subjects with asthma in remission (p < 0.001), compared with the controls. The thickness of I-M complex was significantly increased in the patients of I, II, III group, compared with the controls (p < 0.001). The endothelium parameter levels: sVCAM-1 (H = 56.11, p = 0.0001), FMD% (H = 43.20, p = 0.0000), the thickness of I-M complex (H = 49.37, p = 0.0000) depend on the severity of the disease. Correlations between the endothelium and pulmonary function parameters were proved (p < 0.05). Conclusions: Endothelial dysfunction in children with asthma was determined. Dependence of severity of the disease on functional state of the vascular endothelium was proved.

Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study

“…Accumulating evidence suggests that low-grade chronic systemic inflammation and autoimmune diseases are risk factors for cardiovascular disease (CVD). Several studies have shown an increased risk of CVD in patients with asthma [ 2 , 3 , 4 , 5 ], chronic obstructive pulmonary disease (COPD) [ 6 , 7 , 8 , 9 , 10 ], cystic fibrosis (CF) [ 11 , 12 , 13 , 14 ], alpha1-antitrypsin deficiency [ 15 , 16 ], and obstructive sleep apnea [ 17 ]. For improved prognosis and to prevent amplifying CVD, understanding the association between pulmonary diseases and CVD has important implications for disease management and targeted treatments.…”

Progress in Pulmonary Rehabilitation of Patients Undergoing Thoracoscopic Radical Resection of Lung Cancer

“…Quality of life is an important indicator to evaluate the effectiveness of postoperative pulmonary rehabilitation, and is also one of the ultimate indicators of clinical rehabilitation treatment, covering 5 aspects including physical health, mental health, social function, daily life activities and good sense of self. The quality of life scale (EORTC-QLQ-C30) and the Lung Cancer Specific Scale (EORTC-QLQ-LC13) of the European Organization for Research and Treatment of Cancer (EORTC) can be used to evaluate the quality of life [46].…”

FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD)

“…In asthma and COPD, endothelial dysfunction, along with vessel inflammation, has been observed (Green and Turner, 2017). Moreover, in asthmatic children, the extent of endothelial dysfunction, as manifested by excess production of circulating vascular cell adhesion molecule-1 (sVCAM-I), was found to be associated with asthma severity (Butov et al, 2019), indicating the critical role of ECs in asthma pathogenesis. Indeed, in light that ECs serves as the gateway of inflammatory cells' transendothelial migration into the lung parenchyma, the activation of ECs, e.g., expression of adhesion molecules and pro-inflammatory mediators, would be crucial in modulating inflammatory cell recruitment.…”